top of page

Vida Ventures' Arjun Goyal shares his thoughts on the current environment in biotech

Arjun Goyal describes how firms are trying to navigate both the private and public markets, why rightsized pipelines might be here to stay, and areas of interest in science.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page